• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雾化两性霉素B-聚甲基丙烯酸纳米颗粒预防可防止侵袭性曲霉病。

Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis.

作者信息

Shirkhani Khojasteh, Teo Ian, Armstrong-James Darius, Shaunak Sunil

机构信息

Departments of Medicine, Infectious Diseases, Immunity and Chemistry, Imperial College London, Hammersmith campus, London, UK.

Departments of Medicine, Infectious Diseases, Immunity and Chemistry, Imperial College London, Hammersmith campus, London, UK.

出版信息

Nanomedicine. 2015 Jul;11(5):1217-26. doi: 10.1016/j.nano.2015.02.012. Epub 2015 Mar 16.

DOI:10.1016/j.nano.2015.02.012
PMID:25791815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4503863/
Abstract

UNLABELLED

Aspergillus species are the major life threatening fungal pathogens in transplant patients. Germination of inhaled fungal spores initiates infection, causes severe pneumonia, and has a mortality of >50%. This is leading to the consideration of pre-exposure prophylaxis to prevent infection. We made a very low MWt amphotericin B-polymethacrylic acid nanoparticle. It was not toxic to lung epithelial cells or monocyte-derived-macrophages in-vitro, or in an in-vivo transplant immuno-suppression mouse model of life threatening invasive aspergillosis. Three days of nebuliser based prophylaxis delivered the nanoparticle effectively to lung and prevented both fungal growth and lung inflammation. Protection from disease was associated with >99% killing of the Aspergillus and a 90% reduction in lung TNF-α; the primary driver of tissue destructive immuno-pathology. This study provides in-vivo proof-of-principle that very small and cost-effective nanoparticles can be made simply, and delivered safely and effectively to lung by the aerosol route to prevent fungal infections.

FROM THE CLINICAL EDITOR

Aspergillus is an opportunistic pathogen, which affects immunocompromised patients. One novel way to help fight against this infection is pre-exposure prophylaxis. The authors here made PMA based anionic hydrogels carrying amphotericin B, with mucoadhesive behavior. They showed that aerosol route of the drug was very effective in protecting against the disease in an in-vivo model and should provide a stepping-stone towards clinical trials in the future.

摘要

未标注

曲霉属是移植患者中主要的危及生命的真菌病原体。吸入的真菌孢子萌发引发感染,导致严重肺炎,死亡率超过50%。这促使人们考虑进行暴露前预防以防止感染。我们制备了一种极低分子量的两性霉素B - 聚甲基丙烯酸纳米颗粒。它在体外对肺上皮细胞或单核细胞衍生的巨噬细胞无毒,在危及生命的侵袭性曲霉病的体内移植免疫抑制小鼠模型中也无毒。基于雾化器的三天预防可将纳米颗粒有效地递送至肺部,并预防真菌生长和肺部炎症。对疾病的保护与>99%的曲霉杀灭率以及肺部肿瘤坏死因子 - α降低90%相关;肿瘤坏死因子 - α是组织破坏性免疫病理学的主要驱动因素。这项研究提供了体内原理证明,即可以简单地制备非常小且经济高效的纳米颗粒,并通过气溶胶途径安全有效地递送至肺部以预防真菌感染。

临床编辑评论

曲霉是一种机会性病原体,会影响免疫功能低下的患者。一种对抗这种感染的新方法是暴露前预防。作者在此制备了携带两性霉素B的基于聚甲基丙烯酸的阴离子水凝胶,具有粘膜粘附行为。他们表明,在体内模型中,药物的气溶胶途径在预防疾病方面非常有效,应为未来的临床试验提供一个跳板。

相似文献

1
Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis.雾化两性霉素B-聚甲基丙烯酸纳米颗粒预防可防止侵袭性曲霉病。
Nanomedicine. 2015 Jul;11(5):1217-26. doi: 10.1016/j.nano.2015.02.012. Epub 2015 Mar 16.
2
Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.雾化脂质体两性霉素B在治疗烟曲霉脓胸中的应用。
Thorax. 1995 Dec;50(12):1321-3. doi: 10.1136/thx.50.12.1321.
3
Efficacy of liposomal amphotericin B for prophylaxis of acute or reactivation models of invasive pulmonary aspergillosis.脂质体两性霉素 B 预防侵袭性肺曲霉病急性或再激活模型的疗效。
Mycoses. 2013 May;56(3):241-9. doi: 10.1111/myc.12011. Epub 2012 Sep 24.
4
Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis.Dectin-2 导向的抗真菌脂质体为肺部曲霉病提供了一种有前景的治疗选择。
mBio. 2021 Feb 23;12(1):e00030-21. doi: 10.1128/mBio.00030-21.
5
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.单次肺部给予两性霉素 B 吸入粉预防豚鼠侵袭性肺曲霉病的疗效。
J Antimicrob Chemother. 2012 Apr;67(4):970-6. doi: 10.1093/jac/dkr567. Epub 2012 Jan 11.
6
Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.抗真菌预防对小鼠侵袭性肺曲霉病有效。
Antimicrob Agents Chemother. 2006 Aug;50(8):2895-6. doi: 10.1128/AAC.00299-06.
7
Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.雾化脂质体两性霉素B治疗曲霉性肺病:病例系列及文献综述
Mycoses. 2015 Mar;58(3):173-80. doi: 10.1111/myc.12294.
8
Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.雾化两性霉素B联合静脉注射两性霉素B治疗重症侵袭性肺曲霉病大鼠
Antimicrob Agents Chemother. 2006 May;50(5):1852-4. doi: 10.1128/AAC.50.5.1852-1854.2006.
9
Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis.雾化脂质体两性霉素B治疗实验性肺曲霉病的疗效
Antimicrob Agents Chemother. 2005 Jul;49(7):3028-30. doi: 10.1128/AAC.49.7.3028-3030.2005.
10
An evaluation of nebulised amphotericin B deoxycholate (Fungizone ) for treatment of pulmonary aspergillosis in the UK National Aspergillosis Centre.英国国家曲霉病中心评价雾化两性霉素 B 去氧胆酸盐(两性霉素 B 脂质体)治疗肺部曲霉病的疗效。
Mycoses. 2019 Nov;62(11):1049-1055. doi: 10.1111/myc.12996.

引用本文的文献

1
Hydrogel applications: a promising frontier in pneumonia therapy.水凝胶应用:肺炎治疗中一个充满前景的前沿领域。
Front Bioeng Biotechnol. 2025 Jun 20;13:1602259. doi: 10.3389/fbioe.2025.1602259. eCollection 2025.
2
Formulation and clinical translation of inhalable nanomedicines for the treatment and prevention of pulmonary infectious diseases.用于治疗和预防肺部感染性疾病的可吸入纳米药物的制剂与临床转化
Drug Deliv Transl Res. 2025 Apr 29. doi: 10.1007/s13346-025-01861-5.
3
Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?

本文引用的文献

1
Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus.吞噬作用依赖的TLR9-BTK-钙调神经磷酸酶-NFAT途径激活协调对烟曲霉的固有免疫。
EMBO Mol Med. 2015 Mar;7(3):240-58. doi: 10.15252/emmm.201404556.
2
Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).雾化两性霉素B(NAB)治疗重症哮喘合并真菌致敏(SAFS)及变应性支气管肺曲霉病(ABPA)的疗效与安全性。
J Asthma. 2015 Apr;52(3):289-95. doi: 10.3109/02770903.2014.958853. Epub 2014 Sep 23.
3
A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft.
肺会是两性霉素B对抗真菌大军的门户吗?
Pharmaceutics. 2022 Dec 3;14(12):2707. doi: 10.3390/pharmaceutics14122707.
4
Sphingosine as a New Antifungal Agent against and spp.鞘氨醇作为一种新型抗真菌剂,可对抗 和 。
Int J Mol Sci. 2022 Dec 7;23(24):15510. doi: 10.3390/ijms232415510.
5
Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections.用于治疗和预防支气管肺侵袭性霉菌感染的吸入性抗真菌药物
Pharmaceutics. 2022 Mar 14;14(3):641. doi: 10.3390/pharmaceutics14030641.
6
Effective Inhibition of Invasive Pulmonary Aspergillosis by Silver Nanoparticles Biosynthesized with Leaf Extract.用叶提取物生物合成的银纳米颗粒对侵袭性肺曲霉病的有效抑制作用
Nanomaterials (Basel). 2021 Dec 25;12(1):51. doi: 10.3390/nano12010051.
7
Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis.基于纳米材料的抗真菌疗法用于对抗曲霉病、球孢子菌病、毛霉菌病和念珠菌病等真菌疾病。
Pathogens. 2021 Oct 12;10(10):1303. doi: 10.3390/pathogens10101303.
8
Future Directions for Clinical Respiratory Fungal Research.临床呼吸真菌研究的未来方向。
Mycopathologia. 2021 Oct;186(5):685-696. doi: 10.1007/s11046-021-00579-5. Epub 2021 Sep 29.
9
Recent applications and strategies in nanotechnology for lung diseases.纳米技术在肺部疾病中的最新应用与策略
Nano Res. 2021;14(7):2067-2089. doi: 10.1007/s12274-020-3180-3. Epub 2021 Jan 8.
10
A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis.治疗肺曲霉病的干粉吸入剂配方新趋势的批判性综述
Pharmaceutics. 2020 Nov 28;12(12):1161. doi: 10.3390/pharmaceutics12121161.
单次局部给予酶响应水凝胶可提高血管化复合移植物的长期存活率。
Sci Transl Med. 2014 Aug 13;6(249):249ra110. doi: 10.1126/scitranslmed.3008778.
4
Antifungal prophylaxis in pediatric lung transplantation: an international multicenter survey.儿童肺移植中的抗真菌预防:一项国际多中心调查。
Pediatr Transplant. 2014 Jun;18(4):393-7. doi: 10.1111/petr.12263.
5
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series.γ干扰素作为侵袭性真菌感染的辅助免疫治疗:病例系列。
BMC Infect Dis. 2014 Mar 26;14:166. doi: 10.1186/1471-2334-14-166.
6
Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.两性霉素 B 通过阻止 IFITM3 介导的限制来增加甲型流感病毒感染。
Cell Rep. 2013 Nov 27;5(4):895-908. doi: 10.1016/j.celrep.2013.10.033. Epub 2013 Nov 21.
7
A new and clinically relevant murine model of solid-organ transplant aspergillosis.一种新的、具有临床相关性的实体器官移植曲霉病的小鼠模型。
Dis Model Mech. 2013 May;6(3):643-51. doi: 10.1242/dmm.010330. Epub 2012 Dec 20.
8
Renal allograft recipients fail to increase interferon-γ during invasive fungal diseases.肾移植受者在侵袭性真菌感染期间未能增加干扰素-γ。
Am J Transplant. 2012 Dec;12(12):3437-40. doi: 10.1111/j.1600-6143.2012.04254.x. Epub 2012 Sep 13.
9
Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers.用糖基化树枝状聚合物预防传染性腹泻中的急性肠壁损伤。
EMBO Mol Med. 2012 Sep;4(9):866-81. doi: 10.1002/emmm.201201290. Epub 2012 Aug 6.
10
Murine infection models for Aspergillus terreus pulmonary aspergillosis reveal long-term persistence of conidia and liver degeneration.鼠类曲霉属土曲霉肺部曲霉病感染模型显示,分生孢子和肝脏变性长期存在。
J Infect Dis. 2012 Apr 15;205(8):1268-77. doi: 10.1093/infdis/jis193.